University of Surrey

Test tubes in the lab Research in the ATI Dance Research

Consequences of non-alcoholic fatty liver disease on drug-induced hepatocytoxicity.

ALGHAMDI, SHAREEFA (2015) Consequences of non-alcoholic fatty liver disease on drug-induced hepatocytoxicity. Doctoral thesis, University of Surrey.

[img]
Preview
Text
PhD thesis-final Plus corrections.pdf - Thesis (version of record)
Available under License Creative Commons Attribution Non-commercial Share Alike.

Download (5MB) | Preview
[img] Text
2014_08_13_Author_Deposit_Agreement.docx - Thesis (version of record)
Available under License Creative Commons Attribution Non-commercial Share Alike.

Download (39kB)

Abstract

Non-alcoholic fatty liver disease (NAFLD) is characterised by the accumulation of lipid in liver. Liver is the principal organ involved in drug biotransformation. The central hypothesis of this project is that alterations in the liver environment due to lipid accumulation aggravate sensitivity of hepatocytes to toxicity of some commonly prescribed drugs (paracetamol, alcohol, phenobarbital, cisplatin or doxorubicin). The aim of this study was to investigate the effect of lipid overloading (steatosis) on drug cytotoxicity in the liver model Huh7 cell line. Hepatic steatosis was induced in Huh7 cells by exposing cells to 300 μM FFA mixture or 1 mM oleic acid. Impact of steatosis on drug toxicity was examined by co-treating the cells with FFA and paracetamol, alcohol, phenobarbital, cisplatin or doxorubicin. Cell viability MTT assay showed that neither 300 μM FFA mixture nor 1 mM OA caused significant reduction in cell viability after 24 h incubation. However, a significant reduction seen after incubation for 48 h, therefore for the subsequent experiments the time frame chosen was 24 h. The results showed that 300 μM FFA mixture did not induce a significant amount of intracellular lipid, whereas 1 mM OA induced significant amount of intracellular lipid. The subsequent experiments were carried out to test the hypothesis that lipid-loaded Huh7 cells are more sensitive to drug toxicity. Co-treatment with FFA and either paracetamol, ethanol or doxorubicin resulted in further reduction in cell viability. Phenobarbital resulted in enhanced cell viability, and no significant changes in cell viability observed after co-treatment with cisplatin. To investigate mode of cell death, caspase3/7 activity was measured as mediator of apoptosis. Generally, an advance apoptosis was observed in steatotic cells treated with the different drugs. Reactive oxygen species were measured as a possible trigger of apoptosis. A significant amount of ROS were generated by FFAs, and generally, drug treatment induced a higher significant amount of ROS in the steatotic Huh7 cells. To elucidate the specific changes observed upon treatment of steatotic cells with hepatotoxic drugs, a single FFA dose (300 μM FFA mixture) and a single drug (doxorubicin) were selected to identify major alterations in gene expression. The microarray data confirmed alterations in oxidative stress-related genes. Such changes were functionally relevant as confirmed by cellular assay and In-Cell Western blot. In conclusion, the hypothesised effect of steatosis on drug toxicity has been confirmed and steatosis may enhance drug toxicity through changing cellular oxidative state and activating the apoptotic pathway.

Item Type: Thesis (Doctoral)
Divisions : Theses
Authors :
AuthorsEmailORCID
ALGHAMDI, SHAREEFAs.al-ghamdi@surrey.ac.ukUNSPECIFIED
Date : 31 July 2015
Funders : King Abdulaziz University-Saudi Arabia
Contributors :
ContributionNameEmailORCID
Thesis supervisorPlant, KEK.Plant@surrey.ac.ukUNSPECIFIED
Thesis supervisorPlant, NJN.Plant@surrey.ac.ukUNSPECIFIED
Depositing User : Shareefa Alghamdi
Date Deposited : 11 Aug 2015 10:54
Last Modified : 11 Aug 2015 10:54
URI: http://epubs.surrey.ac.uk/id/eprint/808210

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year


Information about this web site

© The University of Surrey, Guildford, Surrey, GU2 7XH, United Kingdom.
+44 (0)1483 300800